Exametazime

Product NDC
51808-214
11-digit product format
518080214
Labeler code
51808
Product ID
51808-214_dd2d8053-37a4-465d-9086-2bd084c4898c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Exametazime
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
AnazaoHealth Corporation
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2012-07-01
Marketing end
0000-00-00
Substance
EXAMETAZIME
Active strength
1 mg/1
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f2265993-8bd7-4a7d-bf41-09c31b647f03Product name120230719

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51808-214-012019-11-27C16284748780-19855d018-d4b1-cd31-e053-dbdaa90ab51aExametazime (HMPAO) (for the preparation of Tc99m Exametazime injection)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51808-214-01ExametazimeHMPAO1 in 1 KITINJECTION, POWDER, LYOPHILIZED,16

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51808-214EXAMETAZIME HMPAO (EXAMETAZIME) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION]6Legacy NDC, 1 package rows20121129_6ea1fd48-c649-4e05-856e-bb123ce40a3f.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
51808-214-01518080214011 in 1 KITHistorical